Impact of Socio-aesthetic Care in the Quality of Life of Patients Treated for Lymphoma During and After Hospitalization

NCT ID: NCT02072655

Last Updated: 2016-06-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-01-31

Study Completion Date

2016-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In the early 2000s , professional and patient organizations are mobilizing to highlight the psychosocial impact of cancer disease , not only during but also after the acute phase.

In 2003, the government launched the Cancer Plan I reinforced in December 2011 by the Cancer Plan II whose objectives include : " Develop a personalized care taking into account the pain and psychological and social support " and " increase opportunities for patients to benefit from supportive care "and" promote the professional integration .

This study aims to show that beyond the immediate benefits of the social aesthetic cares in hospital (direct soothing, improving the quality of the skin injured by chemotherapy , feeling of escape ... ), these treatments can also affect quality of life for patients during and after hospitalization. They also may have an impact on the maintenance of social and / or professional satisfactory throughout the planned chemotherapy aplastic period .

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Lymphoma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

without socio-asthetic care

Group Type NO_INTERVENTION

No interventions assigned to this group

with socio-aesthetic cares

Group Type EXPERIMENTAL

socio-aesthetic care

Intervention Type PROCEDURE

* care of the face
* skin cleansing with cleansing milk to remove impurities
* a gentle scrub to exfoliate and cleanse the skin
* a relaxing massage
* moisturizing mask
* application of a moisturizer suited to specific patient skin: skin reactivity, dehydration ...
* care manicure / pedicure,
* massages
* makeup, advice (scarves, wigs care products adapted to the skin changes ...) and helping relationship.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

socio-aesthetic care

* care of the face
* skin cleansing with cleansing milk to remove impurities
* a gentle scrub to exfoliate and cleanse the skin
* a relaxing massage
* moisturizing mask
* application of a moisturizer suited to specific patient skin: skin reactivity, dehydration ...
* care manicure / pedicure,
* massages
* makeup, advice (scarves, wigs care products adapted to the skin changes ...) and helping relationship.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 18 to 65 years old
* Hospitalized in the Hematology care unit in UH Angers
* Initial Hodgkin lymphoma, diffuse large B-cell lymphoma and mantle cell lymphoma
* Without previous socio-aesthetic care.

Exclusion Criteria

* Age \<18 years old.
* Patient protected by the law.
* Patient at end of life.
* Patient unable to respond to the questionnaire.
* Previous Socio aesthetic care.
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Angers

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hematology Care Unit - UH Angers

Angers, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

AOI PM 2012-12

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.